We have also shown that VIM-positive (CK19−/VIM+) CTC-enriched blood fractions, unlike CK19+/VIM− fractions, show elevated CXCR4 and uPAR levels, which might contribute to more aggressive tumor characteristics. This evidence concerns the gene VIM and neoplasm.